The largest database of trusted experimental protocols

Human msc nucleofector kit

Manufactured by Lonza
Sourced in Switzerland

The Human MSC Nucleofector Kit is a laboratory equipment product designed for the electroporation-based transfection of human mesenchymal stem cells (hMSCs). It provides the necessary reagents and protocols for efficient gene delivery into hMSCs.

Automatically generated - may contain errors

21 protocols using human msc nucleofector kit

1

Overexpression of HLA-G1 in Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM-MSC nucleofection was performed according to Human MSC Nucleofector Kit (Lonza) protocol. Briefly, 4 × 105 MSC were resuspended in 100 μl of nucleofection buffer with 2 μg pDNA (MC-HLA-G1, pmax-HLA-G1, or pEP-HLA-G1) and pulsed with the U-23 program of the Amaxa Nucleofection device (Lonza). After nucleofection, cells were carefully transferred to MSCGM, and the cell number and percent viability estimated using Trypan Blue. Cells were then replated at 3,000 cells/cm2 and kept in culture at 37 °C and 5% CO2 in a humidified atmosphere. HLA-G1 expression levels were measured by flow cytometric analysis 2 and 10 days after nucleofection. Non-nucleofected cells were used as a control, as were MSC only pulsed with U-23 (no pDNA). Cell recovery and rate of nucleofection were determined using equations previously described by Madeira et al.34 (link) MSC nucleofected with plasmids encoding HLA-G1 were designated nvMSC-HLA-G1.
+ Open protocol
+ Expand
2

Generating Engineered hMSCs for Therapeutic PGIS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human bone marrow-derived mesenchymal stem cells (hMSCs, between passages 3 and 4; Lonza (PT2501), Switzerland) were transfected by electroporation (Human MSC Nucleofector Kit, Lonza) to introduce a plasmid pcDNA 3.1 (Invitrogen, Carlsbad, CA, USA) or a pcDNA 3.1 expressing a triple-catalytic hybrid enzyme that links COX-1 to PGIS (the hybrid enzyme [COX-1-10aa-PGIS])8 (link). After nucleofection, cells were grown under G418 (200 μg ml−1) selection, and confluent cell monolayers were collected for evaluation of stable expression of the transgene COX-1-10aa-PGIS. hMSCs containing pcDNA 3.1 were referred to as 3.1-hMSCs and those containing pCOX-1-10aa-PGIS were referred to as PGI2-hMSCs.
+ Open protocol
+ Expand
3

Silencing Experiments in U2OS Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Silencing experiments were performed with Lipofectamine RNAiMAX Transfection Reagent (Life Technologies) according to the manufacturer's instructions. ING1b, PIAS4 stealth RNAi siRNAs (Life Technologies) and HIF1α siRNA (SC-35561, Santa Cruz Biotechnology, CliniSciences, Nanterre, France) were used in experiments. A Stealth RNAi siRNA Negative Control (Life Technologies) was used as control.
Stably transfected U2OS cells were previously produced using the empty pcDNA 3.1 vector, pcDNA 3.1 ING1b WT (coding for ING1b) and pcDNA 3.1 ING1b E195 and selected with G148 (0.5 mg/ml).15 (link)Transient transfections with empty pcDNA 3.1 (control), pcDNA 3.1 Flag ING1b WT plasmids were performed on ADSCs using a Human MSC Nucleofector Kit and the Nucleofector device (Lonza).
+ Open protocol
+ Expand
4

Measuring FRET in Transfected hMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
One million hMSCs were transfected with 10 μg DNA using the 4D-Nucleofector™ System together with Human MSC Nucleofector® Kit (Lonza) on high-efficiency settings. Following nucleofection the cells were plated in DMEM/ps with 10% FBS overnight to recover before passaging onto PAM gels in DMEM/ps with 0.5% FBS. Images for analysis were collected on a LSM710 Zeiss confocal microscope equipped with a 40X water immersion objective (Zeiss, Jena, GER) using a heated stage at 37 °C with 5% CO2 atmosphere. CFP and FRET channels were recorded using a 458 nm laser line and collecting the emissions in the donor (BP 470e490 nm) and acceptor (BP 530e590 nm) emission regions, respectively. In addition, crosstalk and YFP channels were recorded using the 514 nm laser line for excitation and collecting the emission in the donor and acceptor emission regions. Images were acquired by sequential acquisition. For FRET measurements, a modified version of the FRET emission ratio was used to calculate this parameter on a pixel-by-pixel basis, as described previously14 (link). The FRET index was calculated for every image as the average [FRET/Donor] emission ratio for selected regions of interest. Greater than 20 cells were tested per condition and repeated using multiple MSC donors.
+ Open protocol
+ Expand
5

RANKL Knockout gRNA Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RANKL specific gRNA construct (pNV-RANKL/KO) is based on the parenteral gRNA-Cas9-2A-GFP vector, which is transiently expressing gRNA and Cas9 and enables GFP selection of transfected MSCs, was purchased from abm (Richmond, Canada). Three vectors were purchased with the following gRNA sequences: pNV-RANKL1/KO—5’-CAGGAATTACAACATATCGT-3’ (472221110290), pNV-RANKL2/KO—5’-CAGCGATGGTGGATGGCTCA-3’ (472221110390), pNV-RANKL3/KO—5’-TTAATAGTGAGATGAGCAAA-3’ (472221110490). pmaxGFP (purchased from Lonza, Human MSC Nucleofector® Kit) was used to control transfection efficiency. Plasmids were propagated by transforming Escherichia Coli (Mix&Go! Competent Cells—DH5 Alpha, Zymo Research) using standard procedures. The plasmids were purified using the ZymoPURE™ II Plasmid Midiprep Kit (Zymo Research) according to the manufacturer’s instructions. The plasmid concentration was measured with the NanoDrop™ One. The plasmids were stored at—20°C.
+ Open protocol
+ Expand
6

Nucleofection of BM-MSCs with HLA-G1

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM-MSC nucleofection was performed according to Human MSC Nucleofector Kit (Lonza) protocol. Briefly, 4 × 105 MSC were resuspended in 100 μl of nucleofection buffer with 2 μg pDNA (MC-HLA-G1, pmax-HLA-G1, or pEP-HLA-G1) and pulsed with the U-23 program of the Amaxa Nucleofection device (Lonza). After nucleofection, cells were carefully transferred to MSCGM, and the cell number and percent viability estimated using Trypan Blue. Cells were then replated at 3,000 cells/cm2 and kept in culture at 37 °C and 5% CO2 in a humidified atmosphere. HLA-G1 expression levels were measured by flow cytometric analysis 2 and 10 days after nucleofection. Non-nucleofected cells were used as a control, as were MSC only pulsed with U-23 (no pDNA). Cell recovery and rate of nucleofection were determined using equations previously described by Madeira et al.34 (link) MSC nucleofected with plasmids encoding HLA-G1 were designated nvMSC-HLA-G1.
+ Open protocol
+ Expand
7

Knockdown of IDO in Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To knock down IDO, the ON-TARGETplus SMART-pool small interfering RNA (siRNA) (L-010337-01-0005; GE Dharmacon, Lafayette, CO, USA) was used. The sequences were as follows: Human IDO1, NM_002164, sense, 5′-UCACCAAAUCCACGAUCAUUU-3′, antisense, 5′-PUAUGCGAAGAACACUGAAAUU-3′; sense, 5′-UUUCAGUGUUCUUCGCAUAUU-3′, antisense, 5′-PUAUGCGAAGAACACUGAAAUU-3′; sense, 5′-GUAUGAAGGGUUCUGGGAAUU-3′, antisense, 5′-PUUCCCAGAACCCUUCAUACUU-3′; and sense, 5′-GAACGGGACACUUUGCUAAUU-3′, antisense, 5′-PUUAGCAAAGUGUCCCGUUCUU-3′. The ON-TARGETplus siCONTROL Nontargeting Pool (D-001810-10-05; GE Dharmacon) was used as the negative control. siRNAs were transfected into MSCs by the Amaxa Nucleofector II device (Lonza) and the Human MSC Nucleofector kit (Lonza). Briefly, aliquots of 5 × 105 MSCs were re-suspended in 100 μl of the Nucleofector solution in the presence of 1.5 μg of IDO or control siRNA and then electroporated by the U-23 program. Cells were immediately transferred into 37 °C pre-warmed complete culture medium and plated onto six-well dishes. After 72 h from transfection, cells were harvested and lysed for the immunoblotting measurement of IDO levels, while the supernatants were recovered for the assessment of IDO activity and to be used in functional assays.
+ Open protocol
+ Expand
8

Transient Knockdown of β-catenin and NF-κB in MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transient transfection of β-catenin siRNA, RelA/p65 siRNA (Stealth RNAi duplex siRNA, Invitrogen) or control siRNA (SiRNA-A, Santa Cruz Biothech., Inc.) into human MSCs or KM101 cells was performed by electroporation with the Human MSC Nucleofector Kit (Lonza) according to the manufacturer’s instruction and as we described44 (link). In briefly, cells were harvested by trypsinization, and resuspended one million cells in 100 μL of human MSC nucleofector solution with 100 pmole of β-catenin, p65 or control siRNA. Electroporation was performed in NucleofectorTM II with program U-23 provided by Lonza/Amaxa Biosystems. Immediately after electroporation, MSCs were transferred into 6 or 24-well plates or 60 mm dishes in MEM-α with 10% FBS-HI and KM101 cells were transferred into 60 mm dishes in IMEM with 10% FBS-HI. After confluence, cells were used for Western blot assays (60 mm dishes) and SA-β-Gal staining (6-well plates) or the medium was changed into osteogenic medium for 7 days to analyze osteogenic marker ALP enzyme activity (24-well plates).
+ Open protocol
+ Expand
9

Tracking hMSC Biodistribution via GFP

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hMSC were transfected with green fluorescent protein (GFP)-carrying plasmid by electroporation using the human MSC nucleofector kit (Lonza, Walkersville, US). GFP-labeled hMSC were seeded on plastic plate or nano-fiber for 24 hours then used for treatment. Three days later, collected the tissues including ankle, spleen, LN, lung, liver and kidney. The hMSC were detected by GFP and human beta actin (ACTB) expression using PCR or anti-GFP immunohistochemistry staining (rabbit polyclonal anti-GFP antibody, at 1∶50 dilution (ab6556, Abcam, Cambridge, UK)). HRP-conjugated goat anti-rabbit secondary antibody was used and the antigens were visualized using a DAB substrate.
For PCR, the primer sequences and conditions were as follows: GFP, 5′- AGGACAGCGTGATCTTCACC- 3′ (forward) and 5′-CTTGAAGTGCATGTGGCTGT -3′ (reverse) (TM, melting temperature; 55°C, 35 cycles); human ACTB, 5′-AGCGAGCATCCCCCAAAGTT -3′ (forward) and 5′-GGGCACGAAGGCTCATCATT-3′ (reverse) (TM, melting temperature; 55°C, 35 cycles). The ladder for PCR electrophoresis is OneSTEP Marker 4 (Wako, Osaka, Japan). 2% agarose gel was used for electrophoresis. The suitable range of the ladder is 72 to1,353 bps. The size of GFP is 153 bps. Three times of biological replicates were used and each independent experiment was performed by triplicates.
+ Open protocol
+ Expand
10

Imaging Adhesion Markers in Equine BMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Passage 3 to 4 equine BMSCs (n = 3) were nucleofected with the fluorescent-protein tagged adhesion markers paxillin mEmerald and vinculin mApple using a human MSC nucleofector kit (Lonza, Basel, Switzerland). Cells were passaged at 48 h post-nucleofection and plated onto 12-well fibronectin-coated glass plates at a concentration of 2 × 103 cells/cm2 in serum-free media (Dulbecco’s modified Eagles’ media, 1000 mg/L glucose; 1 ng/mL bFGF; 25 mM HEPES; 100 units/mL penicillin-streptomycin). BMSCs were plated in the presence and absence of 100 mM β-lactose (Santa Cruz Biotechnology Inc., Dallas, TX, USA). At 8 h post-plating, glass plates were fixed in 4% paraformaldehyde for 10 minutes, rinsed in PBS, followed by actin staining with phalloidin Alexa647 and nuclear staining with DAPI for 15 minutes, followed by several PBS rinses. Cells were imaged with a × 100, NA 1.3 objective on an Olympus IX83 microscope equipped with a Yokagawa X1 spinning disk confocal scanning unit and an Andor Ultra 897 EMCCD camera. Images were overlaid in Adobe Photoshop CS5 (Adobe Systems Inc., San Jose, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!